After BioAge Labs raised nearly $200 million in its IPO this week, several companies are beginning to eye the public markets, ...
Biotech IPOs are making a comeback alongside the sector’s recent gains as funding constraints fueled by record-high interest ...
In the HY primary two issues were priced totaling US$1.2bn, lifting weekly supply to US$9.195bn and September volume to US$36.625bn, according to IFR data. The average IG bond spread was unchanged at ...
BioAge Labs stock rose Thursday on the company's upsized IPO — reflecting enthusiasm for its approach to obesity treatments.
(Alliance News) - RTW Biotech Opportunities Ltd on Friday noted that portfolio firm BioAge Labs Inc has completed a USD198 million initial public offering.
London, UK-based Vicebio raised $100 million in a Series B that will help to fund the development of its Molecular Clamp ...